135 related articles for article (PubMed ID: 26122033)
1. Wnt Signaling in Rhabdomyosarcoma - A Potential Targeted Therapy Option.
Chen E
Curr Drug Targets; 2016; 17(11):1245-51. PubMed ID: 26122033
[TBL] [Abstract][Full Text] [Related]
2. Hedgehog Pathway Drives Fusion-Negative Rhabdomyosarcoma Initiated From Non-myogenic Endothelial Progenitors.
Drummond CJ; Hanna JA; Garcia MR; Devine DJ; Heyrana AJ; Finkelstein D; Rehg JE; Hatley ME
Cancer Cell; 2018 Jan; 33(1):108-124.e5. PubMed ID: 29316425
[TBL] [Abstract][Full Text] [Related]
3. HDAC8 regulates canonical Wnt pathway to promote differentiation in skeletal muscles.
Ferrari L; Bragato C; Brioschi L; Spreafico M; Esposito S; Pezzotta A; Pizzetti F; Moreno-Fortuny A; Bellipanni G; Giordano A; Riva P; Frabetti F; Viani P; Cossu G; Mora M; Marozzi A; Pistocchi A
J Cell Physiol; 2019 May; 234(5):6067-6076. PubMed ID: 30246374
[TBL] [Abstract][Full Text] [Related]
4. Recent Insights into Notch Signaling in Embryonal Rhabdomyosarcoma.
Conti B; Slemmons KK; Rota R; Linardic CM
Curr Drug Targets; 2016; 17(11):1235-44. PubMed ID: 26343114
[TBL] [Abstract][Full Text] [Related]
5. Dysregulated Myogenesis in Rhabdomyosarcoma.
Yu PY; Guttridge DC
Curr Top Dev Biol; 2018; 126():285-297. PubMed ID: 29305002
[TBL] [Abstract][Full Text] [Related]
6. Myogenesis and rhabdomyosarcoma the Jekyll and Hyde of skeletal muscle.
Saab R; Spunt SL; Skapek SX
Curr Top Dev Biol; 2011; 94():197-234. PubMed ID: 21295688
[TBL] [Abstract][Full Text] [Related]
7. Wnt Signaling in Skeletal Muscle Development and Regeneration.
Girardi F; Le Grand F
Prog Mol Biol Transl Sci; 2018 Jan; 153():157-179. PubMed ID: 29389515
[TBL] [Abstract][Full Text] [Related]
8. Interfering with Hedgehog Pathway: New Avenues for Targeted Therapy in Rhabdomyosarcoma.
Manzella G; Schäfer BW
Curr Drug Targets; 2016; 17(11):1228-34. PubMed ID: 25944015
[TBL] [Abstract][Full Text] [Related]
9. Role of microRNAs in skeletal muscle development and rhabdomyosarcoma (review).
Ju H; Yang Y; Sheng A; Jiang X
Mol Med Rep; 2015 Jun; 11(6):4019-24. PubMed ID: 25633282
[TBL] [Abstract][Full Text] [Related]
10. Different requirements for Wnt signaling in tongue myogenic subpopulations.
Zhong Z; Zhao H; Mayo J; Chai Y
J Dent Res; 2015 Mar; 94(3):421-9. PubMed ID: 25576472
[TBL] [Abstract][Full Text] [Related]
11. Tumor suppressive functions of WNT5A in rhabdomyosarcoma.
Ragab N; Bauer J; Uhmann A; Marx A; Hahn H; Simon-Keller K
Int J Oncol; 2022 Sep; 61(3):. PubMed ID: 35796028
[TBL] [Abstract][Full Text] [Related]
12. The muscle-specific microRNA miR-206 blocks human rhabdomyosarcoma growth in xenotransplanted mice by promoting myogenic differentiation.
Taulli R; Bersani F; Foglizzo V; Linari A; Vigna E; Ladanyi M; Tuschl T; Ponzetto C
J Clin Invest; 2009 Aug; 119(8):2366-78. PubMed ID: 19620785
[TBL] [Abstract][Full Text] [Related]
13. Hedgehog/Patched-associated rhabdomyosarcoma formation from delta1-expressing mesodermal cells.
Nitzki F; Cuvelier N; Dräger J; Schneider A; Braun T; Hahn H
Oncogene; 2016 Jun; 35(22):2923-31. PubMed ID: 26387541
[TBL] [Abstract][Full Text] [Related]
14. MicroRNAs involved in skeletal muscle development and their roles in rhabdomyosarcoma pathogenesis.
Novák J; Vinklárek J; Bienertová-Vašků J; Slabý O
Pediatr Blood Cancer; 2013 Nov; 60(11):1739-46. PubMed ID: 23813576
[TBL] [Abstract][Full Text] [Related]
15. HIF modulation of Wnt signaling regulates skeletal myogenesis in vivo.
Majmundar AJ; Lee DS; Skuli N; Mesquita RC; Kim MN; Yodh AG; Nguyen-McCarty M; Li B; Simon MC
Development; 2015 Jul; 142(14):2405-12. PubMed ID: 26153230
[TBL] [Abstract][Full Text] [Related]
16. MiRNAs as Players in Rhabdomyosarcoma Development.
Gasparini P; Ferrari A; Casanova M; Limido F; Massimino M; Sozzi G; Fortunato O
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31752446
[TBL] [Abstract][Full Text] [Related]
17. Wnt signaling in skeletal muscle dynamics: myogenesis, neuromuscular synapse and fibrosis.
Cisternas P; Henriquez JP; Brandan E; Inestrosa NC
Mol Neurobiol; 2014 Feb; 49(1):574-89. PubMed ID: 24014138
[TBL] [Abstract][Full Text] [Related]
18. Activation of the hypoxia-inducible factor 1α promotes myogenesis through the noncanonical Wnt pathway, leading to hypertrophic myotubes.
Cirillo F; Resmini G; Ghiroldi A; Piccoli M; Bergante S; Tettamanti G; Anastasia L
FASEB J; 2017 May; 31(5):2146-2156. PubMed ID: 28188178
[TBL] [Abstract][Full Text] [Related]
19. Genomic and Epigenetic Changes Drive Aberrant Skeletal Muscle Differentiation in Rhabdomyosarcoma.
Pomella S; Danielli SG; Alaggio R; Breunis WB; Hamed E; Selfe J; Wachtel M; Walters ZS; Schäfer BW; Rota R; Shipley JM; Hettmer S
Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345159
[TBL] [Abstract][Full Text] [Related]
20. LEF1 reduces tumor progression and induces myodifferentiation in a subset of rhabdomyosarcoma.
Dräger J; Simon-Keller K; Pukrop T; Klemm F; Wilting J; Sticht C; Dittmann K; Schulz M; Leuschner I; Marx A; Hahn H
Oncotarget; 2017 Jan; 8(2):3259-3273. PubMed ID: 27965462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
